Lutz Kaufner Selected Research

Lutz Kaufner Research Topics

Disease

10	Hemorrhage 10/2023 - 05/2012
4	Anemia 02/2024 - 11/2016
4	Wounds and Injuries (Trauma) 10/2023 - 09/2012
3	Pain (Aches) 05/2023 - 01/2016
3	Postpartum Hemorrhage 10/2022 - 05/2017
2	Placenta Accreta 05/2023 - 05/2023
2	Neoplasms (Cancer) 01/2023 - 08/2017
2	Inflammation (Inflammations) 10/2022 - 09/2019
2	Hypertension (High Blood Pressure) 08/2020 - 01/2012
2	Bradycardia 01/2019 - 01/2012
2	Post-Dural Puncture Headache 11/2017 - 10/2017
2	Ovarian Epithelial Carcinoma 03/2015 - 03/2014
1	Venous Thromboembolism 05/2023
1	Disseminated Intravascular Coagulation 04/2023
1	Liver Diseases (Liver Disease) 04/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Dementia (Dementias) 01/2023
1	Frailty 01/2023
1	COVID-19 01/2021
1	Activated Protein C Resistance (APC Resistance) 01/2021
1	Exanthema (Rash) 08/2020
1	Fever (Fevers) 08/2020
1	Constipation 08/2020
1	Placenta Previa 09/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Malnutrition (Nutritional Deficiencies) 08/2017
1	Delirium 08/2017
1	Lacerations 10/2016
1	Postoperative Pain 01/2016
1	Pulmonary Embolism 03/2014
1	Atrial Fibrillation 03/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2014
1	Stroke (Strokes) 03/2014
1	Myocardial Infarction 03/2014
1	Ascites 03/2014
1	Shoulder Dystocia 01/2012
1	Embolism (Embolus) 01/2012
1	Substance-Related Disorders (Drug Abuse) 10/2011

Drug/Important Bio-Agent (IBA)

3	Fibrinogen (Factor I)FDA Link 01/2021 - 10/2016
3	AnticoagulantsIBA 04/2016 - 03/2014
3	recombinant FVIIa (rFVIIa)FDA Link 03/2014 - 05/2012
2	Hemostatics (Antihemorrhagics)IBA 05/2023 - 05/2023
2	ChitosanIBA 10/2022 - 09/2019
2	Hemoglobins (Hemoglobin)IBA 10/2022 - 09/2019
1	Anesthetics (Anesthetic Agents)IBA 05/2023
1	thiamine triphosphorate (TTP)IBA 04/2023
1	Blood Coagulation Factors (Coagulation Factor)IBA 04/2023
1	Peptide Hydrolases (Proteases)FDA Link 04/2023
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2021
1	AntithrombinsIBA 01/2021
1	Factor V (Coagulation Factor V)IBA 01/2021
1	PlasminogenIBA 01/2021
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2021
1	Protein CIBA 01/2021
1	Thromboplastin (Tissue Factor)IBA 01/2021
1	Protein SIBA 01/2021
1	IronIBA 08/2020
1	Crystalloid SolutionsIBA 01/2019
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2019
1	Colloids (Colloid)IBA 01/2019
1	theodrenaline drug combination cafedrineIBA 01/2019
1	Opioid Analgesics (Opioids)IBA 01/2016
1	Local AnestheticsIBA 01/2016
1	Analgesics (Analgesic Drugs)IBA 01/2016
1	Prothrombin (Factor II)IBA 03/2014
1	Factor Xa (Coagulation Factor Xa)IBA 03/2014
1	RivaroxabanIBA 03/2014
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2014
1	edoxabanIBA 03/2014
1	Thrombin FDA Link 03/2014
1	apixabanIBA 03/2014
1	Dabigatran FDA Link 03/2014
1	Factor VII (Proconvertin)IBA 09/2012
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 09/2012
1	prothrombin complex concentrates (PPSB)IBA 09/2012
1	Tranexamic Acid (AMCA)FDA Link 09/2012
1	A-factor (Streptomyces)IBA 09/2012

Therapy/Procedure

7	Cesarean Section (Caesarean Section) 09/2019 - 01/2012
6	Therapeutics 05/2023 - 09/2012
4	Blood Transfusion (Blood Transfusions) 02/2024 - 03/2014
3	Anesthesia 05/2023 - 01/2016
3	Cytoreduction Surgical Procedures 01/2023 - 03/2014
2	Epidural Analgesia 11/2017 - 10/2017
2	Analgesia 11/2017 - 10/2017
1	Contraindications 10/2023
1	Postoperative Care 05/2023
1	Plasma Exchange 04/2023
1	Neoadjuvant Therapy 01/2023
1	Rehabilitation 01/2023
1	Reoperation 01/2023
1	Treatment Delay 10/2022
1	Hysterectomy 10/2022
1	Early Ambulation 08/2017
1	Episiotomy 10/2016
1	Epidural Anesthesia 01/2016
1	Length of Stay 03/2014
1	Obstetrical Anesthesia 10/2011